Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Boehringer Ingelheim
Dow
AstraZeneca
Mallinckrodt

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

KERLONE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Kerlone patents expire, and what generic alternatives are available?

Kerlone is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in KERLONE is betaxolol hydrochloride. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the betaxolol hydrochloride profile page.

Summary for KERLONE
Drug patent expirations by year for KERLONE
Recent Clinical Trials for KERLONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Centre Hospitalier Universitaire de Saint EtiennePhase 4

See all KERLONE clinical trials

Synonyms for KERLONE
(.+/-.)-1-[p-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)-2-propanol
(3-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-2-hydroxypropyl)(propan-2-yl)amine
1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol
1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-(isopropylamino)propan-2-ol
1-(4-[2-(Cyclopropylmethoxy)ethyl]phenoxy)-3-(isopropylamino)-2-propanol #
1-(isopropylamino)-3-[p-(cyclopropylmethoxyethyl)phenoxy]-2-propanol
1-[(4-{2-[(cyclopropylmethyl)oxy]ethyl}phenyl)oxy]-3-[(1-methylethyl)amino]propan-2-ol
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)-2-propanol
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol
1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-(propan-2-ylamino)propan-2-ol
2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-
2-Propanol,1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-
63659-18-7
63659-19-8 (hydrochloride)
659X187
A834454
AB2000495
AC-1115
AC1L1DIZ
AK546815
AKOS015841671
ALO-1401-02
AN-1136
API0024704
AS-14125
BC227945
BDBM50405521
beta-Xolol
betaxolol
Betaxolol (Betoptic)
Betaxolol (INN)
Betaxolol (TN)
Betaxolol [INN:BAN]
Betaxolol HCL
Betaxolol S
Betaxololum
Betaxololum [INN-Latin]
Betoptic
Betoptic S
BPBio1_000621
BRD-A02759312-003-03-9
BRD-A02759312-003-11-2
BSPBio_000563
C-19113
C06849
C18H29NO3
CAS-63659-18-7
CC-24642
CCG-204288
CHEBI:3082
CHEMBL423
CS-2452
CTK8F0838
D07526
DB00195
DSSTox_CID_2674
DSSTox_GSID_22674
DSSTox_RID_76685
DTXSID2022674
FT-0601531
GTPL549
HMS2089I07
HMS3655P17
HY-B0381
I14-16995
K005
KERLEDEX
KM0772
KS-00001F72
L000125
Lopac0_000193
LS-122005
MolPort-003-845-027
MRF-0000336
NCGC00015159-04
NCGC00015159-05
NCGC00015159-06
NCGC00015159-08
NCGC00015159-09
NCGC00015159-11
NCGC00024863-03
NCGC00024863-04
NWIUTZDMDHAVTP-UHFFFAOYSA-N
Prestwick0_000382
Prestwick1_000382
Prestwick2_000382
Prestwick3_000382
Q-200713
s2091
SC-23071
SCHEMBL23530
SL 75212
SL-75212
SL-75212-10
SPBio_002484
SW196917-5
TC-030604
Tox21_110091
Tox21_110091_1

US Patents and Regulatory Information for KERLONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us KERLONE betaxolol hydrochloride TABLET;ORAL 019507-001 Oct 27, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
Sanofi Aventis Us KERLONE betaxolol hydrochloride TABLET;ORAL 019507-002 Oct 27, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
McKinsey
Medtronic
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.